The SARS-CoV-2 Neutralization Antibody Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain of the viral spike glycoprotein (RBD) with the cell surface receptor ACE2 in human whole blood, serum or plasma. It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2.
Easy visually interpretation
Simple operation, no equipment required
|Reading Time||10 minutes|
|Shelf Life||2 Years|
|ICN-CT402||SARS-CoV-2 Neutralization Antibody Rapid Test||WB/S/P||25T|